LEADER 03228nam 22005055 450 001 9910349376003321 005 20200701141847.0 010 $a3-658-27352-6 024 7 $a10.1007/978-3-658-27352-1 035 $a(CKB)4100000008869928 035 $a(MiAaPQ)EBC5844349 035 $a(DE-He213)978-3-658-27352-1 035 $a(PPN)238487768 035 $a(EXLCZ)994100000008869928 100 $a20190731d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aInhaled sedation in the intensive care unit $eA new option and its technical prerequisites /$fby Andreas Meiser 205 $a1st ed. 2019. 210 1$aWiesbaden :$cSpringer Fachmedien Wiesbaden :$cImprint: Springer,$d2019. 215 $a1 online resource (58 pages) $cillustrations 311 $a3-658-27351-8 327 $aThe basic principle of anesthetic reflection -- The AnaConDa, the Mirus, and the AnaConDa-S -- Inhaled sedation in ARDS -- Inhaled sedation and mortality. 330 $aAndreas Meiser summarizes the current literature on inhalation sedation of critically ill patients. To meet clinical demands, he describes the development of new devices to administer volatile anesthetics together with common ICU ventilators. Their basic principle is called anesthetic reflection. The author discusses advantages and drawbacks of these devices in line with clinical studies demonstrating advantages of inhaled versus intravenous ICU sedation. Contents The basic principle of anesthetic reflection The AnaConDa, the Mirus, and the AnaConDa-S Inhaled sedation in ARDS Inhaled sedation and mortality Target Groups Anaesthesiologists, intensive care medical doctors, physicians and intensive care nurses Students and scientists in the field of anaesthesiology and intensive care About the Author Dr. med. Andreas Meiser is working as a consultant anesthesiologist on the interdisciplinary operative ICU of the Saarland University Medical Center. He has been a pioneer in the field of inhalation ICU sedation. He has been treating patients using the AnaConDa administration devices since 2004, and has published many original articles in scientific journals on the subject. 606 $aCritical care medicine 606 $aAnesthesiology 606 $aPharmaceutical technology 606 $aIntensive / Critical Care Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H3100X 606 $aAnesthesiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H13001 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 615 0$aCritical care medicine. 615 0$aAnesthesiology. 615 0$aPharmaceutical technology. 615 14$aIntensive / Critical Care Medicine. 615 24$aAnesthesiology. 615 24$aPharmaceutical Sciences/Technology. 676 $a617.962 700 $aMeiser$b Andreas$4aut$4http://id.loc.gov/vocabulary/relators/aut$0782397 906 $aBOOK 912 $a9910349376003321 996 $aInhaled sedation in the intensive care unit$91736177 997 $aUNINA